• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对霍乱毒素噬菌体CTX Φ感染的霍乱弧菌O1血清群候选疫苗。

A Vibrio cholerae serogroup O1 vaccine candidate against CTX ET Phi infection.

作者信息

Yan Meiying, Liu Guangwen, Diao Baowei, Qiu Haiyan, Zhang Lijuan, Liang Weili, Gao Shouyi, Kan Biao

机构信息

State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, PR China.

出版信息

Vaccine. 2007 May 16;25(20):4046-55. doi: 10.1016/j.vaccine.2007.02.043. Epub 2007 Mar 5.

DOI:10.1016/j.vaccine.2007.02.043
PMID:17428586
Abstract

Cholera is a severe diarrheal disease that may spread rapidly. Vaccination is considered a valid measure against it. We developed a new vaccine candidate, IEM109, against Vibrio cholerae. To generate this candidate, a chromosomal fragment containing the TLC element, attB of the CTX Phi integration site, and RTX cluster responsible for the cytotoxic activity for mammalian cells was deleted through homologous recombination from the previously described El Tor biotype, IEM101. The protective genes ctxB and rstR, which establish resistance to CTX Phi infections, were inserted into that same location on the chromosome of IEM109 to enhance the safety and genetic stability of the vaccine candidate and to prevent horizontal gene transfer. In in vivo tests, cell cultures showed that the cytotoxic effect of IEM109 on Hep-2 was negative. Furthermore, the infection rate of El Tor biotype CTX Phi to that of IEM109 in the rabbit intestine is 3000-fold lower than that of IEM101. Intraintestinal vaccination of rabbits with a single dose of IEM109 elicits high titers of anti-CTB IgG and vibriocidal antibodies. When challenged with 0.5-2 microg CT and 10(5) to 10(8)CFU of four wild toxigenic strains of different biotypes and serogroups, IEM109 conferred full protection. Thus, IEM109 is a stable vaccine candidate that evokes not only antitoxic and vibriocidal immunities, but also resistance to the El Tor biotype CTX Phi infection.

摘要

霍乱是一种可能迅速传播的严重腹泻疾病。疫苗接种被认为是预防霍乱的有效措施。我们研发了一种针对霍乱弧菌的新型候选疫苗IEM109。为了制备该候选疫苗,通过同源重组从先前描述的埃尔托生物型IEM101中删除了包含TLC元件、CTX Φ整合位点的attB以及负责对哺乳动物细胞产生细胞毒性活性的RTX簇的染色体片段。将对CTX Φ感染产生抗性的保护性基因ctxB和rstR插入到IEM109染色体的同一位置,以提高候选疫苗的安全性和遗传稳定性,并防止水平基因转移。在体内试验中,细胞培养显示IEM109对Hep-2细胞的细胞毒性作用为阴性。此外,埃尔托生物型CTX Φ在兔肠道中对IEM109的感染率比IEM101低3000倍。用单剂量IEM109对兔进行肠道内接种可引发高滴度的抗CTB IgG和杀弧菌抗体。当用0.5 - 2微克霍乱毒素以及10^5至10^8 CFU的四种不同生物型和血清群的野生产毒菌株进行攻毒时,IEM109提供了完全保护。因此,IEM109是一种稳定的候选疫苗,它不仅能引发抗毒素和杀弧菌免疫,还能抵抗埃尔托生物型CTX Φ感染。

相似文献

1
A Vibrio cholerae serogroup O1 vaccine candidate against CTX ET Phi infection.一种针对霍乱毒素噬菌体CTX Φ感染的霍乱弧菌O1血清群候选疫苗。
Vaccine. 2007 May 16;25(20):4046-55. doi: 10.1016/j.vaccine.2007.02.043. Epub 2007 Mar 5.
2
Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.安全、活口服霍乱弧菌候选疫苗IEM108的构建与评价
Infect Immun. 2003 Oct;71(10):5498-504. doi: 10.1128/IAI.71.10.5498-5504.2003.
3
Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.用重组毒素调节菌毛和霍乱毒素B亚单位进行鼻内免疫可保护兔子免受霍乱弧菌O1的攻击。
FEMS Immunol Med Microbiol. 2009 Jul;56(2):179-84. doi: 10.1111/j.1574-695X.2009.00563.x. Epub 2009 May 5.
4
[Study on infection of different strains of Vibro cholerae O1 by El Tor CTXPhi].[埃尔托型霍乱毒素噬菌体对不同O1群霍乱弧菌菌株感染的研究]
Wei Sheng Wu Xue Bao. 2005 Oct;45(5):757-62.
5
Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.表达高水平霍乱毒素B亚基的重组秘鲁-15作为抗产肠毒素大肠杆菌疫苗的构建及临床前评估
Vaccine. 2007 Dec 12;25(51):8574-84. doi: 10.1016/j.vaccine.2007.09.074. Epub 2007 Oct 26.
6
Construction and characterization of an auxotrophic ctxA mutant of O139 Vibrio cholerae.构建并鉴定霍乱弧菌 O139 型 ctxA 营养缺陷突变株。
Microb Pathog. 2010 Nov;49(5):211-6. doi: 10.1016/j.micpath.2010.06.001. Epub 2010 Jun 15.
7
A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice.通过鼻腔途径给药的基于蛋白脂质体的制剂可在BALB/c小鼠体内产生针对埃尔托小川型霍乱弧菌O1的杀弧菌抗体。
Vaccine. 2009 Jan 7;27(2):205-12. doi: 10.1016/j.vaccine.2008.10.052. Epub 2008 Nov 7.
8
Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.在孟加拉国受试者口服灭活二价霍乱弧菌O1/O139全细胞霍乱疫苗免疫后,在其黏膜表面检测到强大的肠道相关疫苗特异性抗体分泌细胞反应:与其他黏膜和全身反应的比较。
Vaccine. 2009 Feb 25;27(9):1386-92. doi: 10.1016/j.vaccine.2008.12.041. Epub 2009 Jan 13.
9
The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.候选疫苗霍乱弧菌638对健康志愿者具有霍乱预防作用。
Infect Immun. 2005 May;73(5):3018-24. doi: 10.1128/IAI.73.5.3018-3024.2005.
10
Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.秘鲁-15(霍乱疫苗)的研发:1991-2009 年,一种减毒口服霍乱疫苗。
Expert Rev Vaccines. 2009 Dec;8(12):1643-52. doi: 10.1586/erv.09.137.

引用本文的文献

1
Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days.在冷链外储存 140 天后,一种口服霍乱活疫苗制剂的免疫原性和保护效力。
BMC Immunol. 2020 May 25;21(1):29. doi: 10.1186/s12865-020-00360-1.
2
Genomic science in understanding cholera outbreaks and evolution of Vibrio cholerae as a human pathogen.基因组科学在理解霍乱暴发和霍乱弧菌作为人类病原体的进化方面的作用。
Curr Top Microbiol Immunol. 2014;379:211-29. doi: 10.1007/82_2014_366.
3
Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.
解毒药理学原则:生物制剂的预防、暴露后治疗建议和研究计划的更新。
Br J Pharmacol. 2010 Oct;161(4):721-48. doi: 10.1111/j.1476-5381.2010.00939.x.
4
Genetic diversity of toxigenic and nontoxigenic Vibrio cholerae serogroups O1 and O139 revealed by array-based comparative genomic hybridization.基于芯片的比较基因组杂交技术揭示的产毒和不产毒霍乱弧菌O1和O139血清群的遗传多样性
J Bacteriol. 2007 Jul;189(13):4837-49. doi: 10.1128/JB.01959-06. Epub 2007 Apr 27.